About Mark Graf
Form D filings for Castle Creek Biosciences in 2022 list Mark Graf as director.
Mark Graf first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Graf in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Graf works with at each company, as listed on that company's latest Form D.
Castle Creek Biosciences, Inc. · Form D, May 2, 2022
MG
Matthew Gantz
Executive officer and director
WM
W. Middlekauff
Secretary
MS
Mary Spellman
Executive officer
JA
Jeffrey Aronin
Director
PM
Patrick Morris
Director
AG
Antonio Gracias
Director